期刊
ONCOTARGET
卷 5, 期 12, 页码 4295-4304出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.2009
关键词
ADAMTS; extracellular proteolysis; glioma; IGFBP2; proteomics
资金
- Plan Nacional I+D+i
- Ministerio de Sanidad
- Instituto de Salud Carlos III from Spain
- FEDER [PI10/00883, PI07/1058, PI10/01847]
- Consejeria de Economia, Innovacion y Ciencia-Junta de Andalucia [P10-CTS5865]
- ICREA Funding Source: Custom
Expression of IGFBP2 (Insulin-like Growth Factor Binding Protein 2) has been positively correlated with glioma progression. Although the proteolysis of IGFBP2 has been widely recognized, with consequences as a major modulator of IGFII signaling, the relevance of this post-translational modification has not been well studied in tumors. Using an in vivo proteomic approach by Isotope-Coded Protein Label (ICPL), we identified IGFBP2 as a target of the extracellular protease ADAMTS1 (A Disintegrin And Metalloproteinase with ThromboSpondin motifs 1). Notably, the proteolytic pattern of IGFBP2 was also detected in human glioma culture cells and, more importantly, in all glioma samples evaluated. In addition, high expression of ADAMTS1 correlates with higher levels of cleaved IGFBP2 in glioblastoma multiforme cases. Using gene expression public databases, we confirmed that IGFBP2 is a poor prognosis marker for gliomas, and we also observed an important contribution of ADAMTS1. Finally, we showed the impact of ADAMTS1 on IGFII-mediated IGF1R phosphorylation and cellular migration. Our results support a functional interaction between IGFBP2 and ADAMTS1 and suggest the need to evaluate post-translational modifications of IGFBP2 in glioma, in order to approach new therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据